Table 1 The association of USP35 expression with clinicopathological parameters in gastric cancer.
Variables | N | USP35 expression | |||
|---|---|---|---|---|---|
High n (%) | Low n (%) | Chi-square value | P value | ||
Age | 1.044 | 0.307 | |||
≥60 | 61 | 27 (44.3) | 34 (55.7) | ||
<60 | 41 | 14 (34.1) | 27 (65.9) | ||
Sex | 0.220 | 0.639 | |||
Male | 72 | 30 (41.7) | 42 (58.3) | ||
Female | 30 | 11 (36.7) | 19 (63.3) | ||
T stage | 8.921 | 0.003 | |||
T1-2 | 32 | 6 (18.8) | 26 (81.2) | ||
T3-4 | 70 | 35 (50.0) | 35 (50.0) | ||
N stage | 6.892 | 0.009 | |||
N0 | 51 | 14 (27.5) | 37 (72.5) | ||
N1-3 | 51 | 27 (52.9) | 24 (47.1) | ||
pStage | 7.774 | 0.005 | |||
Ⅰ+Ⅱ | 52 | 14 (26.9) | 38 (73.1) | ||
Ⅲ+Ⅳ | 50 | 27 (54.0) | 23 (46.0) | ||
Grade | 1.699 | 0.192 | |||
G1 + G2 | 30 | 15 (50.0) | 15 (50.0) | ||
G3 | 72 | 26 (36.1) | 46 (63.9) | ||
Peritoneal metastasis | 9.193 | 0.002 | |||
Yes | 20 | 14 (70.0) | 6 (30.0) | ||
No | 82 | 27 (32.9) | 55 (67.1) | ||
